BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38532431)

  • 1. 1,3,5-Triazine: Recent Development in Synthesis of its Analogs and Biological Profile.
    Kumawat J; Jain S; Misra N; Dwivedi J; Kishore D
    Mini Rev Med Chem; 2024 Jun; ():. PubMed ID: 38847171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
    Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthesis of new triazine sulfonamides with antitumor, anti-microbial and anti-SARS-CoV-2 activities.
    Mohamed-Ezzat RA; Elgemeie GH
    BMC Chem; 2024 Mar; 18(1):58. PubMed ID: 38532431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel synthesis of the first new class of triazine sulfonamide thioglycosides and the evaluation of their anti-tumor and anti-viral activities against human coronavirus.
    Mohamed-Ezzat RA; Elgemeie GH
    Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-18. PubMed ID: 38753464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies.
    Barakat A; Mostafa A; Ali M; Al-Majid AM; Domingo LR; Kutkat O; Moatasim Y; Zia K; Ul-Haq Z; Elshaier YAMM
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
    Megally Abdo NY; Milad Mohareb R; Halim PA
    Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of New JAK1 Inhibitors based on Sulfonamide- Triazine Conjugates.
    Daoud S; Taha MO
    Curr Comput Aided Drug Des; 2021; 17(7):916-926. PubMed ID: 33357183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unexpected tautomer: synthesis and crystal structure of
    Mohamed-Ezzat RA; Elgemeie GH; Jones PG
    Acta Crystallogr E Crystallogr Commun; 2024 Feb; 80(Pt 2):120-124. PubMed ID: 38333139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic strategy towards novel composite based on substituted pyrido[2,1-b][1,3,4]oxadiazine-dialdehyde chitosan conjugate with antimicrobial and anticancer activities.
    Mohamed-Ezzat RA; Hashem AH; Dacrory S
    BMC Chem; 2023 Jul; 17(1):88. PubMed ID: 37496066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazolo[4,3-
    Kciuk M; Marciniak B; Celik I; Zerroug E; Dubey A; Sundaraj R; Mujwar S; Bukowski K; Mojzych M; Kontek R
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonamides with Heterocyclic Periphery as Antiviral Agents.
    Moskalik MY
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX.
    Zain-Alabdeen AI; El-Moselhy TF; Sharafeldin N; Angeli A; Supuran CT; El-Hamamsy MH
    Sci Rep; 2022 Oct; 12(1):16756. PubMed ID: 36202955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Novel Pyrazolo[4,3-
    Kciuk M; Mujwar S; Szymanowska A; Marciniak B; Bukowski K; Mojzych M; Kontek R
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682571
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.